INAB
Price:
$1.43
Market Cap:
$6.63M
IN8bio, Inc. is a biotechnology firm currently in the clinical trial phase, dedicated to identifying, advancing, and bringing to market gamma-delta T cell-based treatments specifically for various forms of cancer. The company's primary therapeutic asset, INB-200, is an autologous (patient-derived) gamma-delta T cell product that has been genetically engineered and is presently undergoing a Phase I clinical study for glioblastoma and other solid tumor malignancies. Additionally, INB-100, an allogeneic (donor-derived) candidate, is also in a Phase I clinical trial, aiming to treat acute leukemia patients undergoing hematopoietic stem cell transplantation. Further development includes preclinic...[Read more]
Industry
Biotechnology
IPO Date
2021-07-30
Stock Exchange
NASDAQ
Ticker
INAB
According to IN8bio, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -0.56. This represents a change of 18.08% compared to the average of -0.47 of the last 4 quarters.
The mean historical PE Ratio of IN8bio, Inc. over the last ten years is -609.34. The current -0.56 PE Ratio has changed -90.81% with respect to the historical average. Over the past ten years (40 quarters), INAB's PE Ratio was at its highest in in the March 2026 quarter at -0.32. The PE Ratio was at its lowest in in the March 2018 quarter at -2790.18.
Average
-609.34
Median
-109.88
Minimum
-2790.18
Maximum
-0.53
Discovering the peaks and valleys of IN8bio, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 0%
Maximum Annual PE Ratio = -0.53
Minimum Annual Increase = -96.12%
Minimum Annual PE Ratio = -2790.18
| Year | PE Ratio | Change |
|---|---|---|
| 2025 | -0.53 | -96.12% |
| 2024 | -13.58 | -67.04% |
| 2023 | -41.20 | -19.12% |
| 2022 | -50.95 | -69.82% |
| 2021 | -168.80 | -75.12% |
| 2020 | -678.55 | -40.00% |
| 2019 | -1130.96 | -59.47% |
The current PE Ratio of IN8bio, Inc. (INAB) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-18.44
5-year avg
-55.01
10-year avg
-609.34
IN8bio, Inc.’s PE Ratio is less than TransCode Therapeutics, Inc. (-0.12), less than Aptevo Therapeutics Inc. (-0.19), greater than HCW Biologics Inc. (-1.65), less than Lyra Therapeutics, Inc. (-0.24), greater than Kiora Pharmaceuticals, Inc. (-0.96), less than Galecto, Inc. (-0.12), less than Aprea Therapeutics, Inc. (-0.44), less than Acurx Pharmaceuticals, Inc. (-0.31), greater than BioCardia, Inc. (-1.22), greater than Phio Pharmaceuticals Corp. (-1.14),
| Company | PE Ratio | Market cap |
|---|---|---|
| -0.12 | $5.07M | |
| -0.19 | $10.45M | |
| -1.65 | $2.67M | |
| -0.24 | $781.13K | |
| -0.96 | $11.30M | |
| -0.12 | $34.47M | |
| -0.44 | $4.46M | |
| -0.31 | $2.49M | |
| -1.22 | $5.10M | |
| -1.14 | $12.43M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like IN8bio, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like IN8bio, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is IN8bio, Inc.'s PE Ratio?
How is the PE Ratio calculated for IN8bio, Inc. (INAB)?
What is the highest PE Ratio for IN8bio, Inc. (INAB)?
What is the 3-year average PE Ratio for IN8bio, Inc. (INAB)?
What is the 5-year average PE Ratio for IN8bio, Inc. (INAB)?
How does the current PE Ratio for IN8bio, Inc. (INAB) compare to its historical average?